Pamela Ann Connealy - 26 Mar 2024 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
CFO & COO
Signature
/s/ Pamela Connealy
Issuer symbol
PYXS
Transactions as of
26 Mar 2024
Net transactions value
$0
Form type
4
Filing time
28 Mar 2024, 16:33:47 UTC
Previous filing
30 Nov 2023
Next filing
21 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Award $0 +328,710 +42% $0.000000 1,110,293 26 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest 25% on the first anniversary of March 26, 2024, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.